Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Medicare Reimbursement Issues Enter Health Reform Debate
New legislation introduced yesterday would attempt to shift Medicare reimbursement policy to reward patient health outcomes, rather than the volume of services provided, MinnPost, a nonprofit online news organization, reports. "We need to be sure to keep score," said Sen. Amy Klobuchar, D-Minn., who introduced the bill, according to MinnPost. "That means measuring outcomes and rewarding providers that deliver quality results."
generic viagra online
Advances In Genomic Medicine Will Mean Massive Changes For The NHS It Is Now Time To Prepare For Them - Lords Science Committee
The House of Lords Science and Technology Committee has published a report on Genomic Medicine which argues that recent developments in genomic science stemming from the sequencing of the human genome represent a unique opportunity for real advances in medical care and that the Government and the NHS must take a range of steps to ensure that these advances are realised.
News of the day
Altair Therapeutics Reports Successful Completion Of Phase I Study Of Inhaled AIR645
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, reported results from its phase I study evaluating the safety, tolerability and pharmacokinetics of its lead product, once-weekly inhaled AIR645, in healthy volunteers. AIR645 is a non-steroidal dual inhibitor of cellular responses to interleukin (IL)-4 and IL-13, cytokines that play a critical role in development and progression of asthma, rhinitis and other allergic disorders. Results presented today at the 2009 International Conference of the American Thoracic Society (ATS) within the Mini-Symposium "New Treatment Approaches for Asthma and Allergy" showed that inhaled AIR645 was safe, well tolerated and had dose-dependent exposure in the airways. These results demonstrate the potential of AIR645 as a convenient once-weekly treatment for asthma and other respiratory disorders. Later this year, Altair plans to initiate a phase II efficacy study in patients with asthma.
Oncology

Mozambique's Health Minister Reviews Country's Health Status With Parliament

A nationwide vaccination effort in Mozambique helped to slash the number of reported cases of measles in Mozambique in 2008, Health Minister Ivo Garrido said Wednesday when addressing the country"s parliament, Agencia de Informacao de Mocambique/allAfrica.com reports. Garrido also reported that 2008 marked the year that leprosy "ceased to be a public health problem in Mozambique" and malaria cases and deaths fell while the number of patients receiving antiretrovirals continued to climb - growing "from 6,000 in December 2004 to over 140,000 at the end of May this year." During the same period, the number of doctors in Mozambique also rose 35 percent, allowing what equates to "one doctor for every 23,000 inhabitants," AIM/allAfrica.com writes. In Mozambique, health services are "essentially free of charge" -hospitalizations are free and consultations "cost the equivalent of 20 U.S. cents," according to AIM/allAfrica.com. "This was the case, [Garrido] declared, because the government "believes that health care is a duty of the state, and a fundamental human right"" (AIM/allAfrica.com, 6/3). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009